Lataa...

Targeting CLL-1 for acute myeloid leukemia therapy

Despite major scientific discoveries and novel therapies over the past four decades, the treatment outcomes of acute myeloid leukemia (AML), especially in the adult patient population remain dismal. In the past few years, an increasing number of targets such as CD33, CD123, CLL-1, CD47, CD70, and TI...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Hematol Oncol
Päätekijät: Ma, Hongbing, Padmanabhan, Iyer Swaminathan, Parmar, Simrit, Gong, Yuping
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6480870/
https://ncbi.nlm.nih.gov/pubmed/31014360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0726-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!